Speaker
Description
Background: Gastric cancer is one of the most common and deadly cancers globally and most cases are attributable to modifiable risk factors, particularly Helicobacter pylori infections. Survival remains low globally and varies between populations. We estimate the current and future avoidable deaths among people diagnosed with gastric cancer in 2024 to inform targeted gastric cancer prevention.
Methods: National gastric cancer estimates, population attributable fractions, life tables and 5-year net survival estimates were taken from the literature. We estimated numbers of avoidable deaths within 5 years of diagnosis for patients diagnosed with gastric cancer in 2024, consisting of those deaths avoidable through primary prevention (preventable deaths) and those avoidable through early detection and improved access to treatment (treatable deaths) by country, region, and human development index (HDI) group. Treatable deaths were estimated by eliminating survival differences using 5-year net survival estimates from the literature. The projected avoidable deaths were estimated to 2050 with an age-period-cohort model fitted to historical incidence.
Findings: Globally, an estimated 429,500 out of 678,200 expected deaths among people at five years after gastric cancer diagnosis were avoidable (63.3%). Out of these, 392,200 deaths were preventable and 37,300 were treatable. Helicobacter pylori infections was the top contributor with 274,700 preventable deaths. Given that no risk factor prevention takes place, early detection and curative treatment improvements could avert a maximum of 194,000 deaths (28.6%). All regions had more than half of deaths avoidable. The proportion of avoidable deaths globally was higher in women than in men (66.6 vs 61.5%) while the age-standardised mortality rate was almost double in men (7.6 vs 3.9 avoidable deaths per 100,000 people). The number of avoidable gastric cancer deaths globally are expected to increase by 31.5% between 2024 and 2050.
Interpretation: Nearly two-thirds of deaths among people diagnosed with gastric cancer globally could be avoided, mainly through primary prevention targeting Helicobacter pylori. Our study highlights the urgent need for, and potential of, coordinated global interventions especially for primary prevention strategies targeting Helicobacter pylori elimination and tobacco smoking while also scaling up early detection and curative treatment.